Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Small Cell
  • Cisplatin
  • Ditiocarb
  • Lung Neoplasms
  • Ovarian Neoplasms

abstract

  • This study did not demonstrate a significant chemoprotective effect against cisplatin-induced toxicities with the DDTC dose schedule tested. Patients who received DDTC received lower cumulative doses of cisplatin, but were more likely to be withdrawn from treatment early due to chemotherapy-related toxicities.

publication date

  • February 1995

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7844610

Additional Document Info

start page

  • 490

end page

  • 6

volume

  • 13

number

  • 2